ANI Pharmaceuticals Inc’s recently made public that its Director Pera Antonio R unloaded Company’s shares for reported $0.69 million on Sep 03 ’25. In the deal valued at $94.94 per share,7,292 shares were sold. As a result of this transaction, Pera Antonio R now holds 22,660 shares worth roughly $2.23 million.
Then, ANTONIO R PERA bought 7,292 shares, generating $692,270 in total proceeds.
Before that, Leonard Matthew J sold 2,528 shares. ANI Pharmaceuticals Inc shares valued at $229,087 were divested by the Director at a price of $90.62 per share. As a result of the transaction, Leonard Matthew J now holds 6,864 shares, worth roughly $0.68 million.
H.C. Wainwright initiated its ANI Pharmaceuticals Inc [ANIP] rating to a Buy in a research note published on July 10, 2025; the price target was $84. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. JP Morgan began covering ANIP with “an Overweight” recommendation on March 12, 2025. Leerink Partners started covering the stock on December 11, 2024. It rated ANIP as “an Outperform”.
Price Performance Review of ANIP
On Tuesday, ANI Pharmaceuticals Inc [NASDAQ:ANIP] saw its stock jump 3.42% to $98.46. Over the last five days, the stock has gained 4.63%. ANI Pharmaceuticals Inc shares have risen nearly 62.05% since the year began. Nevertheless, the stocks have risen 78.11% over the past one year. While a 52-week high of $96.56 was reached on 09/09/25, a 52-week low of $52.50 was recorded on 01/13/25.
Levels Of Support And Resistance For ANIP Stock
The 24-hour chart illustrates a support level at 96.28, which if violated will result in even more drops to 94.09. On the upside, there is a resistance level at 99.57. A further resistance level may holdings at 100.67.
How much short interest is there in ANI Pharmaceuticals Inc?
A steep rise in short interest was recorded in ANI Pharmaceuticals Inc stocks on 2025-08-15, growing by 75162.0 shares to a total of 2.2 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 2.13 million shares. There was a rise of 3.41%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 11, 2024 when Piper Sandler began covering the stock and recommended ‘”an Overweight”‘ rating along with a $68 price target.
